课题基金 / 基金详情

项目摘要

项目成果

Wendy L. Havran的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): The protein C pathway plays important roles in coagulation, inflammation and wound healing. The endothelial protein C receptor (EPCR) is the specific receptor for activated protein C (APC). EPCR is expressed by human keratinocytes and may promote cell survival, growth and migration in normal skin homeostasis and wound healing. Interestingly, EPCR was recently described as a stress- regulated molecule on endothelial cells and epithelial tumors that could directly bind to a human V?4V¿5 T cell receptor and elicit expansion of the T cells in response to CMV infection and malignancy. EPCR is a type 1 transmembrane protein that is structurally similar to MHC molecules and binds lipids analogous to CD1d. Together these findings raise the possibility that EPCR may stimulate the stress response of ?¿ T cells under different conditions, including tissue damage. Indeed, ?¿ T cells that reside in epithelial tissues provide a crucial first line of defense against infection, trauma and malignancy. In the skin, dendritic epidermal T cells (DETC) express a monoclonal V?3V¿1 TCR that recognizes an unknown antigen expressed by damaged or diseased keratinocytes. We propose to test the hypothesis that EPCR can provide a stress-signal of damage or disease in the epidermis to neighboring DETC to activate their wound healing functions. We will test this hypothesis by determining if the DETC TCR can interact with EPCR and by investigating whether EPCR expression during wound healing impacts epidermal ?¿ T cell wound healing responses. If found to be a prototypic stress-signal for ?¿ T cell activation, EPCR may then be a useful target in future strategies to improve healing of chronic wounds as well as other skin inflammatory diseases and malignancies.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Expression of gamma delta TCR ligands in development
  • 批准号:
    9332915
  • 项目类别:
  • 资助金额:
    $28.88万
  • 财政年份:
    2017
  • 负责人:
    Wendy L. Havran
  • 依托单位:
CD1-lipid reactivity of epidermal T cells
  • 批准号:
    8809549
  • 项目类别:
  • 资助金额:
    $25.01万
  • 财政年份:
    2015
  • 负责人:
    Wendy L. Havran
  • 依托单位:
Mechanism-Based Wound Healing by Activation of gamma delta T Cells
  • 批准号:
    9104102
  • 项目类别:
  • 资助金额:
    $25.65万
  • 财政年份:
    2015
  • 负责人:
    Wendy L. Havran
  • 依托单位:
CD1-lipid reactivity of epidermal T cells
  • 批准号:
    9050634
  • 项目类别:
  • 资助金额:
    $20.85万
  • 财政年份:
    2015
  • 负责人:
    Wendy L. Havran
  • 依托单位:
国内基金
海外基金
Neo-antigens暴露对肾移植术后体液性排斥反应的影响及其机制研究
  • 批准号:
    2022J011295
  • 项目类别:
    省市级项目
  • 资助金额:
    10.0万元
  • 批准年份:
    2022
  • 负责人:
    王亚伟
  • 依托单位:
结核分枝杆菌持续感染期抗原(latency antigens)的重组BCG疫苗研究